INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2023

Coffee intake is linked to positive health outcomes in chronic liver disease, potentially via both caffeine-dependent and caffeine-independent mechanisms.

Epidemiological studies over the past decade consistently associate coffee consumption with positive health outcomes in patients with chronic liver disease, including decreased liver-related mortality. Because coffee contains many constituent molecules influenced by source, roasting, and preparation, identifying its mechanisms of action has been challenging. While caffeine acting as a liver adenosine receptor antagonist is hypothesized as a primary active factor, data also suggest caffeine-independent mechanisms. This review evaluates the biological plausibility of these caffeine-independent effects.

Shows an association, not proof of cause and effect.

Study type
Narrative review
Who was studied
Patients with chronic liver disease
What was measured
Liver-related mortality and health outcomes, biological mechanisms

THE PAPER

Coffee as chemoprotectant in fatty liver disease: caffeine-dependent and caffeine-independent effects.

Dranoff JA. Am J Physiol Gastrointest Liver Physiol, 2023.

PubMed 36976807 ↗DOI 10.1152/ajpgi.00026.2023 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.